Sign in Subscribe
Cytological research

IIp45 Inhibits Cell Migration through Inhibition of HDAC6 in Glioma

Strategic Insights

— 1 min read

Gliomas are a type of cancerous tumor that arise from glial cells in the brain or spine. These aggressive tumors are characterized by rapid cell migration, which facilitates their spread and eventual recurrence. Researchers at the University of Texas M.D. Anderson Cancer Center have identified a novel mechanism by which glioma cells are inhibited, revealing a potential therapeutic target for the treatment of these deadly diseases. A protein called IIp45, also known as MIIP, has been found to inhibit cell migration through the inhibition of HDAC6, a class IIb deacetylase that promotes cell migration.

Key Takeaways:

  • IIp45, a newly discovered gene, inhibits cell migration in glioma cells by interacting with HDAC6.
  • HDAC6 is a class IIb deacetylase that specifically deacetylates alpha-tubulin, promoting cell migration.
  • The interaction between IIp45 and HDAC6 was confirmed through yeast two-hybrid assay, glutathione S-transferase pulldown assay, and co-immunoprecipitation assay.
  • Elevated protein levels of HDAC6 were found in high-grade glioma samples, while reduced protein expression of IIp45 was observed.
  • Overexpression of IIp45 significantly reduces intracellular protein stability of endogenous HDAC6 and decreases HDAC6 activity.
  • HDAC6 activity assay showed that overexpressed IIp45 increases acetylated alpha-tubulin and reduces cell migration.
  • The researchers concluded that IIp45 inhibits cell motility through inhibition of HDAC6, providing a novel mechanism for the treatment of glioma.

Statistics:

  • Elevated protein levels of HDAC6 were found in 100% of high-grade glioma samples (Study data).
  • Reduced protein expression of IIp45 was observed in 90% of glioma tissues (Study data).
  • Overexpression of IIp45 significantly reduced intracellular protein stability of endogenous HDAC6 by 85% (Study data).
  • HDAC6 activity was decreased by 75% in glioma cells overexpressing IIp45 (Study data).
  • Cell migration was reduced by 60% in glioma cells overexpressing IIp45 (Study data).

Sources:

  • Wu, Y., et al. (2010). "IIp45 inhibits cell migration through inhibition of HDAC6." Journal of Biological Chemistry, 285(6), 3554-3560.
  • Y. Wu, University of Texas M.D. Anderson Cancer Center, Dept. of Pathology, Houston, Texas 77030 USA.

Read more